Cytosorbents press releases
WebMar 9, 2024 · Cytosorbents press release ( NASDAQ: CTSO ): FY GAAP EPS of -$0.75 beats by $0.14. Revenue of $29.36M (-26.8% Y/Y) misses by $4.69M. Grant Income, was $9.4 million versus $10.8 million in Q4... WebPress Release Virginia Institute of Marine Science - Page 2 Gwartney-Green has been a life science teacher at Peasley since her former school—Page—was destroyed by the …
Cytosorbents press releases
Did you know?
WebMar 22, 2024 · PRINCETON, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced its scientific program for the 42 nd International Symposium on Intensive Care & Emergency … WebOct 12, 2024 · PRINCETON, N.J., Oct. 12, 2024 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
WebMar 22, 2024 · PRINCETON, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac... WebMar 22, 2024 · PRINCETON, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced its scientific program for the 42 nd International Symposium on Intensive Care & Emergency …
WebPR Newswire. There is no web site at this address. Please contact us for assistance. WebNews. Press Releases; Publications; White Papers; Press Kit; Media; Contact. Contact Us; Become A Partner; CytoSorbents Highlights Activities at the Live 41st International …
WebCytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for the U.S. Clinical Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR™ …
Web2 days ago · Press Release Blood Purification Filter Market Current and Future Transformation till 2024-2028Fresenius Medical Care, Baxter, Nipro, Asahi Kasei Published: April 12, 2024 at 2:58 a.m. ET rawlings great handsWebMar 14, 2024 · PRINCETON, N.J., March 14, 2024 (GLOBE NEWSWIRE) — CytoSorbents Corporation(NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced today that it does not have any direct financial … simple gold chain with pearlWebFeb 24, 2024 · MONMOUTH JUNCTION, N.J., Feb. 24, 2024 /PRNewswire/ -- CytoSorbents Corporation CTSO +0.60% + Free Alerts , a leader in the treatment of life-threatening conditions in the intensive care unit and... rawlings gs2fhtc3acdWebMar 22, 2024 · PRINCETON, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation CTSO, a leader in the treatment of life-threatening conditions in the intensive … simple gold heart necklaceWebCytoSorbents Reports Fourth Quarter and Full Year 2024 Results. Pivotal U.S. and Canada STAR-T Trial enrollment passes halfway mark. Positive sales momentum from Q4 2024 continues in Q1 2024 to ... simple gold plated earringsWebJan 23, 2024 · PRINCETON, N.J., Jan. 23, 2024 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ), a leader in the treatment of life-threatening conditions in … simple gold necklaces for womenWebFeb 27, 2024 · CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood purification. Its lead product, CytoSorb®, is... rawlings h115fbm